De hyppigst indberettede uønskede reaktioner, som blev anset for at have en mulig eller sandsynlig forbindelse til emtricitabin og/ eller tenofovirdisoproxilfumarat, var kvalme (12%) og diarré (7%).
The most frequently reported adverse reactions considered possibly or probably related to emtricitabine and/ or tenofovir disoproxil fumarate were nausea (12%) and diarrhoea (7%).